In this week's special episode of The Weekly Dose Podcast we interview Dr Tobias Janowitz, a medical oncologist, assistant professor at the Cold Spring Harbor Laboratories and adjunct professor at the Feinstein Institutes. Dr Janowitz was part of a team that recently conducted a phase 2 clinical trial assessing high doses of famotidine in adults with COVID-19. The trial was conducted completely remotely and the findings were published in Gut. As well as discussing their findings, Dr Janowitz talks about the process of conducting a fully-remote trial and the greater possibilities this may hold for future clinical research.
